Pharmacological application of caffeine inhibits TGF-β-stimulated connective tissue growth factor expression in hepatocytes via PPARγ and SMAD2/3-dependent pathways-Reference-Cited by-同舟云学术

Pharmacological application of caffeine inhibits TGF-β-stimulated connective tissue growth factor expression in hepatocytes via PPARγ and SMAD2/3-dependent pathways

Published:2008-11 Issue:5 Volume:49 Page:758-767
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Gressner Olav A.,Lahme Birgit,Rehbein Katharina,Siluschek Monika,Weiskirchen Ralf,Gressner Axel M.

Publisher

Elsevier BV

Subject

Hepatology

Reference49 articles.

1. Changing the pathogenetic roadmap of liver fibrosis?;Gressner;J Gastroenterol Hepatol,2008

2. Higher caffeine consumption is associated with milder fibrosis in patients with chronic liver diseases;Modi;Hepatology,2007

3. Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States;Ruhl;Gastroenterology,2005

4. Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States;Ruhl;Gastroenterology,2005

5. Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers;Tanaka;Int J Epidemiol,1998

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protective Effect of Caffeine and Chlorogenic Acids of Coffee in Liver Disease;Foods;2024-07-20

2. Exploring the impact of coffee consumption on liver health: A comprehensive bibliometric analysis;Heliyon;2024-05

3. Common Pathogenetic Pathways of Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus;Current Diabetes Reviews;2023-11

4. Clinical, Gender, Socioeconomic Characteristics and Outcomes of Individuals Receiving Hepatitis B Treatment in Ethiopia: 18-Month Follow-Up;The American Journal of Tropical Medicine and Hygiene;2023-11-01

5. Roles of Coffee and Its Components in Liver Diseases;Drug Targets and Therapeutics;2023-09-30